Background: The aim of this study was to retrospectively evaluate the safety and efficacy of a combined CT-guided percutaneous microwave ablation (MWA) and pedicle screw fixation followed by vertebroplasty (MASFVA) for the treatment and stabilization of painful vertebral metastases with vertebral pedicle involvement. (2) Methods: from January 2013 to January 2017 11 patients with 16 vertebral metastatic lesions (7 men and 5 women; mean age, 65 +/- 11 years) with vertebral metastases underwent CT-guided microwave ablation and screw fixation followed by vertebroplasty (MASFVA). Technical success, complication rate, pain evaluation using a visual analogue scale (VAS), Oswestry Disability Index (ODI) and local tumor control were examined. (3) Results: Technical success rate was 100%. No procedure-related major complications occurred. VAS score decreased from 6.8 +/- 0.7 to 0.6 +/- 0.6. ODI score decreased from 3.1 +/- 0.7 to 1.2 +/- 0.4. All patients could walk independently without neurological complication after one week from the procedure. No new bone fractures or local disease recurrence occurred during a median follow-up of 12 months. (4) Conclusions: Our results suggest that MWA and percutaneous pedicle screw fixation followed by vertebroplasty for the treatment of painful vertebral metastases is a safe and effective procedure for painful vertebral metastases with vertebral pedicle involvement, allowing pain relief and local tumor control.

Percutaneous CT-guided microwave ablation combined with pedicle screw fixation followed by vertebroplasty (MASFVA): initial experience of a minimally invasive treatment of vertebral metastases with extension to the vertebral pedicle / Pusceddu, C.; Marsico, S.; Derudas, D.; Ballicu, N.; Melis, L.; de Felice, C.; Calabrese, A.; Santucci, D.; Faiella, E.. - In: CURRENT ONCOLOGY. - ISSN 1718-7729. - 30:2(2023), pp. 1663-1672. [10.3390/curroncol30020127]

Percutaneous CT-guided microwave ablation combined with pedicle screw fixation followed by vertebroplasty (MASFVA): initial experience of a minimally invasive treatment of vertebral metastases with extension to the vertebral pedicle

de Felice C.;Calabrese A.;
2023

Abstract

Background: The aim of this study was to retrospectively evaluate the safety and efficacy of a combined CT-guided percutaneous microwave ablation (MWA) and pedicle screw fixation followed by vertebroplasty (MASFVA) for the treatment and stabilization of painful vertebral metastases with vertebral pedicle involvement. (2) Methods: from January 2013 to January 2017 11 patients with 16 vertebral metastatic lesions (7 men and 5 women; mean age, 65 +/- 11 years) with vertebral metastases underwent CT-guided microwave ablation and screw fixation followed by vertebroplasty (MASFVA). Technical success, complication rate, pain evaluation using a visual analogue scale (VAS), Oswestry Disability Index (ODI) and local tumor control were examined. (3) Results: Technical success rate was 100%. No procedure-related major complications occurred. VAS score decreased from 6.8 +/- 0.7 to 0.6 +/- 0.6. ODI score decreased from 3.1 +/- 0.7 to 1.2 +/- 0.4. All patients could walk independently without neurological complication after one week from the procedure. No new bone fractures or local disease recurrence occurred during a median follow-up of 12 months. (4) Conclusions: Our results suggest that MWA and percutaneous pedicle screw fixation followed by vertebroplasty for the treatment of painful vertebral metastases is a safe and effective procedure for painful vertebral metastases with vertebral pedicle involvement, allowing pain relief and local tumor control.
2023
interventional radiology; microwave ablation; percutaneous therapies; screw fixation; spine metastases; vertebroplasty
01 Pubblicazione su rivista::01a Articolo in rivista
Percutaneous CT-guided microwave ablation combined with pedicle screw fixation followed by vertebroplasty (MASFVA): initial experience of a minimally invasive treatment of vertebral metastases with extension to the vertebral pedicle / Pusceddu, C.; Marsico, S.; Derudas, D.; Ballicu, N.; Melis, L.; de Felice, C.; Calabrese, A.; Santucci, D.; Faiella, E.. - In: CURRENT ONCOLOGY. - ISSN 1718-7729. - 30:2(2023), pp. 1663-1672. [10.3390/curroncol30020127]
File allegati a questo prodotto
File Dimensione Formato  
Pusceddu_Percutaneous CT-Guided_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1677759
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 2
social impact